760178-23-2Relevant articles and documents
COMPOUND RETAINED IN TUMOR
-
, (2011/12/03)
A novel compound which specifically resides in a tumor, a method for allowing it to reside in a tumor, and a method for detecting, diagnosing, and treating tumor with use thereof are provided. The present invention relates to a compound represented by chemical formula (I) wherein R is an anionic group binding to hydrogen, R1 is OH, OCOH, OCO(CH2)hCH3, or an acting group, h being an integer of 0 or more, R2 is H, OH, OCOH, OCO(CH2)iCH3, or an acting group, i being an integer of 0 or more, R3 is OH, SO3H, or an acting group, R4 is OH, SO3H, or an acting group, and R5 is OH, SO3H, or an acting group, at least one of R1, R2, R3, R4, and R5 containing an acting group, or pharmaceutically acceptable salts thereof.
Synthesis of an immunosuppressant SQAG9 and determination of the binding peptide by T7 phage display
Yamazaki, Takayuki,Aoki, Satoko,Ohta, Keisuke,Hyuma, Shinji,Sakaguchi, Kengo,Sugawara, Fumio
, p. 4343 - 4346 (2007/10/03)
SQAG9, a new class of immunosuppressive sulfoquinovosylacylglycerol, and its biotinylated derivatives have been synthesized. A T7 Phage library, composed of random cDNA fragments from Drosophila melanogaster, displayed a possible binding peptide of 14 ami